Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: JAMA Intern Med. 2016 Apr;176(4):496–502. doi: 10.1001/jamainternmed.2015.8462

Table 2. Baseline Characteristics of the International Study Population Stratified According to 30-day Potentially Avoidable Readmission.

No. (%) of patients
Clinical Characteristics Without 30-day
PAR
(n=112,418)
With 30-day
PAR
(n =11,794)
Age, mean (SD) 60.8 (18.3) 61.3 (18.0)

Male sex 53,679 (51%) 5,988 (53%)

Country

    United States 70,550 (89.4%) 8,371
(10.6%)

    Canada 10,221 (92.6%) 820 (7.4%)

    Switzerland 8,971 (94.5%) 524 (5.5%)

    Israel 16,016 (91.0%) 1,592 (9.0%)

Urgent or Emergent index admission 78,708 (74%) 9,369 (83%)

Discharge from an oncology division 6,457 (6.1%) 786 (7.0%)

Length of stay of the index admission ≥ 5 days 45,655 (43%) 6,058 (54%)

Number of hospital admissions in the past year

  ≤ 1 76,196 (72%) 4,826 (43%)

  2-5 25,109 (24%) 4,464 (40%)

  > 5 4,453 (4%) 2,017 (18%)

≥ 1 procedure during the index hospitalization 78,818 (75%) 8,781 (78%)

Low hemoglobin level at discharge (< 12 g/dL) 59,381 (56%) 8,005 (71%)

Low sodium level at discharge ( < 135 mmol/L) 13,520 (13%) 2,038 (18%)

PAR: potentially avoidable readmission